SCHEMBL6865778

SCHEMBL6865778

Cc1cccc(CN2CCN(c3cccc(C(F)(F)F)c3)CC2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.67
POLB P06746 1/20 0.67
SIGMAR1 Q99720 2/20 0.62
ALDH1A1 P00352 6/20 0.61
GAA P10253 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
LMNA P02545 1/20 0.61
TP53 P04637 1/20 0.61
MAPT P10636 2/20 0.61
TDP1 Q9NUW8 3/20 0.60
KDM4C Q9H3R0 1/20 0.60
HTR1A P08908 1/20 0.58
SMO Q99835 1/20 0.57
HTR7 P34969 1/20 0.57
TSHR P16473 2/20 0.57
ALOX15 P16050 1/20 0.57
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C19 P33261 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6862996 0.91 KDM4E (0.74) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL6864697 0.87 SIGMAR1 (0.76) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL6864524 0.86 KDM4E (0.68) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL6863480 0.84 SIGMAR1 (0.67) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL11898006 0.84 KDM4E (0.70) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL15937919 0.84 HTR7 (0.69) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL6858091 0.82 ALDH1A1 (0.76) KDM4EALDH1A1LMNAMAPTHTR7
SCHEMBL7043039 0.82 KDM4E (0.67) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL6864364 0.81 KDM4E (0.63) KDM4EPOLBSIGMAR1ALDH1A1GAA
SCHEMBL13637639 0.80 ALDH1A1 (0.65) KDM4EALDH1A1MAPTHTR7TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800444-B1 USEFUL AS ANTIBACTERIAL AND OTHER PHARMACEUTICAL AGENTS/INTERMEDIATES ISIS PHARMACEUTICALS, INC. 2004-10-05 US disclosed
US-6660466-B1 Reacting reactive appendage compounds such as meta benzylic compounds or alpha-amide compounds with scaffold molecules having reactive functionalities and contacting the intermediate library with a reducing agent ISIS PHARMACEUTICALS, INC. 2003-12-09 US disclosed
US-6150129-A USEFUL AS ANTIBACTERIAL AND OTHER PHARMACEUTICAL AGENTS AND AS INTERMEDIATES FOR PREPARATION OF OTHER PHARMACEUTICAL AGENTS ISIS PHARMACEUTICALS, INC. (US) 2000-11-21 US disclosed
US-6114334-A CENTRAL NERVOUS SYSTEM DISORDERS KNOLL AKTIENGESELLSCHAFT (DE) 2000-09-05 US disclosed
US-5922872-A BACTERICIDES AND DRUGS ISIS PHARMACEUTICALS, INC. (US) 1999-07-13 US disclosed
US-5817489-A BACTERICIDES, OR CHEMICAL INTERMEDIATES THEREOF; DRUG LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-10-06 US disclosed
US-5798360-A ANTIBACTERIAL AGENTS ISIS PHARMACEUTICALS, INC. (US) 1998-08-25 US disclosed
US-5780241-A ALTERING ELECTROCHEMICAL PROPERTIES BY DECYCLIZATION ISIS PHARMACEUTICALS, INC. (US) 1998-07-14 US disclosed
WO-1998020349-A1 COMPLEX CHEMICAL LIBRARIES ISIS PHARMACEUTICALS, INC. (US) 1998-05-14 WO disclosed
US-5731438-A BACTERICIDES; DRUGS ISIS PHARMACEUTICALS, INC. (US) 1998-03-24 US disclosed